Continous glucose monitors (CGMs) received a flurry of US Food and Drug Administration (FDA) appprovals in 2018. Since then, the FDA-approved CGMs have benefited from a variety of enhanced features, new applications, and new approvals that promise to further advance the management of diabetes and thus the functioning and quality of life of patients with diabetes.
Take the 5-question quiz below to see what you know about key original CGM approvals and features and the innovations and advances that have been approved since.
1. Which of the following was the first FDA-approved CGM system to include a fully implantable sensor to detect glucose?